Related references
Note: Only part of the references are listed.Lessons from S1P receptor targeting in multiple sclerosis
Emanuela Colombo et al.
PHARMACOLOGY & THERAPEUTICS (2022)
Efficacy of the sphingosine-1-phosphate receptor agonist fingolimod in animal models of stroke: an updated meta-analysis
Chun Dang et al.
INTERNATIONAL JOURNAL OF NEUROSCIENCE (2021)
Endothelial S1P1 Signaling Counteracts Infarct Expansion in Ischemic Stroke
Anja Nitzsche et al.
CIRCULATION RESEARCH (2021)
The standardization fallacy
Bernhard Voelkl et al.
NATURE METHODS (2021)
Acute Treatment With Fingolimod Does Not Confer Long-Term Benefit in a Mouse Model of Intracerebral Haemorrhage
Andrea C. Diaz Diaz et al.
FRONTIERS IN PHARMACOLOGY (2021)
The effect of fingolimod on regulatory T cells in a mouse model of brain ischaemia
Kyle Malone et al.
JOURNAL OF NEUROINFLAMMATION (2021)
Thrombolytic strategies for ischemic stroke in the thrombectomy era
Maxime Gauberti et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2021)
FTY720 Protects Against Ischemia-Reperfusion Injury by Preventing the Redistribution of Tight Junction Proteins and Decreases Inflammation in the Subacute Phase in an Experimental Stroke Model
Zifeng Wang et al.
TRANSLATIONAL STROKE RESEARCH (2020)
Fingolimod Inhibits Inflammation but Exacerbates Brain Edema in the Acute Phases of Cerebral Ischemia in Diabetic Mice
Wanlu Li et al.
FRONTIERS IN NEUROSCIENCE (2020)
The immune system and stroke: from current targets to future therapy
Kyle Malone et al.
IMMUNOLOGY AND CELL BIOLOGY (2019)
Animal models of ischemic stroke and their impact on drug discovery
Dirk M. Hermann et al.
EXPERT OPINION ON DRUG DISCOVERY (2019)
Inflammation and its resolution in atherosclerosis: mediators and therapeutic opportunities
Magnus Back et al.
NATURE REVIEWS CARDIOLOGY (2019)
Repurposing multiple sclerosis drugs: a review of studies in neurological and psychiatric conditions
Paulus Stefan Rommer et al.
DRUG DISCOVERY TODAY (2019)
Immunomodulatory Therapeutic Strategies in Stroke
Kyle Malone et al.
FRONTIERS IN PHARMACOLOGY (2019)
The impact of sex and age on T cell immunity and ischemic stroke outcomes
Hilda Ahnstedt et al.
CELLULAR IMMUNOLOGY (2019)
Distinct Housing Conditions Reveal a Major Impact of Adaptive Immunity on the Course of Obesity-Induced Type 2 Diabetes
Julia Sbierski-Kind et al.
FRONTIERS IN IMMUNOLOGY (2018)
Inflammaging: a new immune-metabolic viewpoint for age-related diseases
Claudio Franceschi et al.
NATURE REVIEWS ENDOCRINOLOGY (2018)
Fingolimod enhances the efficacy of delayed alteplase administration in acute ischemic stroke by promoting anterograde reperfusion and retrograde collateral flow
De-Cai Tian et al.
ANNALS OF NEUROLOGY (2018)
S1PR1 (Sphingosine-1-Phosphate Receptor 1) Signaling Regulates Blood Flow and Pressure
Anna Cantalupo et al.
HYPERTENSION (2017)
Immune cell trafficking across the barriers of the central nervous system in multiple sclerosis and stroke
Melissa A. Lopes Pinheiro et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2016)
Fingolimod: a review of its mode of action in the context of its efficacy and safety profile in relapsing forms of multiple sclerosis
Douglas R. Jeffery et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2016)
Men and mice: Relating their ages
Sulagna Dutta et al.
LIFE SCIENCES (2016)
Fingolimod: a review of its mode of action in the context of its efficacy and safety profile in relapsing forms of multiple sclerosis
Douglas R. Jeffery et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2016)
Epidermal Fatty Acid Binding Protein Promotes Skin Inflammation Induced by High-Fat Diet
Yuwen Zhang et al.
IMMUNITY (2015)
Long-term cardiac safety and tolerability of fingolimod in multiple sclerosis: A postmarketing study
Damiano Paolicelli et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2015)
Results of a preclinical randomized controlled multicenter trial (pRCT): Anti-CD49d treatment for acute brain ischemia
Gemma Llovera et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
Fingolimod exerts neuroprotective effects in a mouse model of intracerebral hemorrhage
Lei Lu et al.
BRAIN RESEARCH (2014)
Immune cell infiltration in malignant middle cerebral artery infarction: comparison with transient cerebral ischemia
Hannah X. Chu et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2014)
Impact of an immune modulator fingolimod on acute ischemic stroke
Ying Fu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Modeling Stroke in Mice: Permanent Coagulation of the Distal Middle Cerebral Artery
Gemma Llovera et al.
JOVE-JOURNAL OF VISUALIZED EXPERIMENTS (2014)
Translational Pharmacokinetic Modeling of Fingolimod (FTY720) as a Paradigm Compound Subject to Sphingosine Kinase-Mediated Phosphorylation
Nelleke Snelder et al.
DRUG METABOLISM AND DISPOSITION (2014)
Fingolimod reduces cerebral lymphocyte infiltration in experimental models of rodent intracerebral hemorrhage
William B. Rolland et al.
EXPERIMENTAL NEUROLOGY (2013)
Systematic Review and Meta-Analysis of the Efficacy of Sphingosine-1-Phosphate (S1P) Receptor Agonist FTY720 (Fingolimod) in Animal Models of Stroke
Junfeng Liu et al.
INTERNATIONAL JOURNAL OF NEUROSCIENCE (2013)
Assessing post-stroke behavior in mouse models of focal ischemia
Mustafa Balkaya et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2013)
Power failure: why small sample size undermines the reliability of neuroscience
Katherine S. Button et al.
NATURE REVIEWS NEUROSCIENCE (2013)
FTY720 Treatment in the Convalescence Period Improves Functional Recovery and Reduces Reactive Astrogliosis in Photothrombotic Stroke
Robert Brunkhorst et al.
PLOS ONE (2013)
Fingolimod Provides Long-Term Protection in Rodent Models of Cerebral Ischemia
Ying Wei et al.
ANNALS OF NEUROLOGY (2011)
The immunology of stroke: from mechanisms to translation
Costantino Iadecola et al.
NATURE MEDICINE (2011)
FTY720 Reduces Post-Ischemic Brain Lymphocyte Influx but Does Not Improve Outcome in Permanent Murine Cerebral Ischemia
Arthur Liesz et al.
PLOS ONE (2011)
Protective Effects of Early CD4+ T Cell Reduction in Hepatic Ischemia/Reperfusion Injury
Mathias Martin et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2010)
Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis
Volker Brinkmann et al.
NATURE REVIEWS DRUG DISCOVERY (2010)
Improving Bioscience Research Reporting: The ARRIVE Guidelines for Reporting Animal Research
Carol Kilkenny et al.
PLOS BIOLOGY (2010)
FTY720 Rescue Therapy in the Dark Agouti Rat Model of Experimental Autoimmune Encephalomyelitis: Expression of Central Nervous System Genes and Reversal of Blood-Brain-Barrier Damage
Carolyn A. Foster et al.
BRAIN PATHOLOGY (2009)
FTY720 (fingolimod) in Multiple Sclerosis: therapeutic effects in the immune and the central nervous system
Volker Brinkmann
BRITISH JOURNAL OF PHARMACOLOGY (2009)
Specific Microbiota Direct the Differentiation of IL-17-Producing T-Helper Cells in the Mucosa of the Small Intestine
Ivaylo I. Ivanov et al.
CELL HOST & MICROBE (2008)
Higher frequency of regulatory T suppressive activity cells in the elderly and increased in neurodegeneration
Daniela Rosenkranz et al.
JOURNAL OF NEUROIMMUNOLOGY (2007)
High accumulation of T regulatory cells prevents the activation of immune responses in aged animals
Sanjay Sharma et al.
JOURNAL OF IMMUNOLOGY (2006)
Selective sphingosine 1-phosphate 1 receptor activation reduces ischemia-reperfusion injury in mouse kidney
AS Awad et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2006)
Share Paper
